SOURCE: Healtheuniverse

September 13, 2005 09:00 ET

Healtheuniverse Announces New Chief Medical Officer and Co-Head of Regenerative Cell and Stem Cell Research

Dr. Slattery and Dr. Dev to Coalesce and Lead Accomplished Team of Researchers in Exploring the Full Ability of Non-Embryonic Stem Cells to Transform Medicine

COVINA, CA -- (MARKET WIRE) -- September 13, 2005 -- Healtheuniverse, Inc. (OTC: HLUN), a biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products announced today the appointment of Kevin Slattery M.D. to the position of Chief Medical Officer and Co-Head of Regenerative Cell and Stem Cell Research. He will assume a full suite of responsibilities working with Healtheuniverse CEO Vipul Dev -- including stem cell research applications, patent application submission, approval, and development of proprietary biopharmaceutical and biomedical products.

Dr. Kevin Slattery received his medical degree from the University of Washington School of Medicine in Seattle, Washington. For the last five years Dr. Slattery has overseen 2 double blind, placebo controlled, multi-centered clinical trials involving low level lasers. The results of the studies were good enough to receive marketing clearance from the FDA on both devices. This was considered a historical event since no company had been able to get a low level laser approved from the FDA since the device was developed in 1961.

Kevin Slattery, Chief Medical Officer of Healtheuniverse, Inc., stated, "Our research strives to avoid the political controversy associated with embryonic stem cell research by utilizing fat cells that have shown the same potential to open up new ways to cure damage to the human body. Every tissue in the body has a population of stem cells and Healtheuniverse will explore this scientific approach and its applications in treating common internal as well as external diseases."

Vipul Dev M.D., Chief Executive Officer of Healtheuniverse, Inc., stated, "Kevin's addition to the Healtheuniverse team reflects the company's commitment to strengthening its corporate culture through scientific collaboration. We strive to foster innovation in our field by bringing together the most forward-thinking scientific and medical innovators and Kevin will be a cornerstone in our development."

About Healtheuniverse, Inc.

HEALTHeUNIVERSE, Inc. is a biotechnology development firm specializing in the development and commercialization of Biopharmaceutical and Biomedical products. We develop and provide early stage project initiation, financing, product commercialization and development of patented and proprietary biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. More information on Healtheuniverse is available online at http://healtheuniverse.com/

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    800-719-7424
    Email Contact